– UK, Manchester – Grafenia plc (LON: GRA) today announced the appointment of Matthias Riechert to its Board as a Non-Executive Director effective from 31 October 2022.
“I’m very happy to have Matthias join our Board. He brings invaluable experience and knowledge that will help us drive the next part of Grafenia’s journey. I’m excited and looking forward to working together.” said CEO, Gavin Cockerill.
About Matthias Riechert
Matthias Riechert is the founder and Director of P&R Investment Management Limited, an investment advisory firm. Previously, Matthias worked in sales and trading at Citigroup Global Markets for nine years. He has an MBA from London Business School and Columbia Business School where he specialised in value investing.
P&R is acting as the mandated investment advisor to Axxion S.A., the alternative investment manager of the P&R Real Value fund. Axxion S.A. currently holds 5,634,919 ordinary shares in Grafenia plc in relation to the P&R Real Value fund, makes its own investment decisions in that regard and is independent of Mr. Riechert.
Commenting on the appointment, Jan Mohr, Chairman of the Company said: “I’m glad Matthias is joining our Board. His successful investing experience in public holding companies will be very beneficial to Grafenia.”
Matthias Riechert said: “I am delighted to join the Board of Grafenia and help the Company become a serial acquirer and a permanent home for great businesses and entrepreneurs. I hope to add value for Grafenia’s team and shareholders by fostering a culture of trust, responsibility, lifelong learning and disciplined capital allocation. I look forward to many years of growth. “
For more information: https://www.grafenia.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.